WallStreetZenWallStreetZen

NASDAQ: AVTX
Avalo Therapeutics Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their AVTX stock forecasts and price targets.

Forecast return on equity

Is AVTX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.5%

Forecast return on assets

Is AVTX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

AVTX revenue forecast

What is AVTX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$1.2M-46.67%
Avg 2 year Forecast
$1.0M-55.56%
Avg 3 year Forecast
$1.0M-55.56%
AVTX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AVTX revenue growth forecast

How is AVTX forecast to perform vs Biotechnology companies and vs the US market?
Company
-24.54%
Industry
38.94%
Market
10.52%
AVTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AVTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AVTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
AVTX$4.75N/AN/A
SNPX$0.19N/AN/A
CMND$1.17N/AN/A
JAGX$0.07N/AN/A
PXMD$0.54$3.00+460.75%Buy

Avalo Therapeutics Stock Forecast FAQ

What is AVTX's revenue growth forecast for 2024-2026?

(NASDAQ: AVTX) Avalo Therapeutics's forecast annual revenue growth rate of -24.54% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Avalo Therapeutics's revenue in 2024 is $2,250,000.On average, 1 Wall Street analysts forecast AVTX's revenue for 2024 to be $961,912, with the lowest AVTX revenue forecast at $961,912, and the highest AVTX revenue forecast at $961,912. On average, 1 Wall Street analysts forecast AVTX's revenue for 2025 to be $801,593, with the lowest AVTX revenue forecast at $801,593, and the highest AVTX revenue forecast at $801,593.

In 2026, AVTX is forecast to generate $801,593 in revenue, with the lowest revenue forecast at $801,593 and the highest revenue forecast at $801,593.

If you're new to stock investing, here's how to buy Avalo Therapeutics stock.

What is AVTX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: AVTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is AVTX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: AVTX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.